HMB (beta-hydroxy-beta-methylbutyrate) is not bad for your liver at standard doses. The FDA granted HMB “Generally Recognized as Safe” (GRAS) status in 2005 and approved daily intake up to 6 grams in 2009. Year-long studies in older adults taking 2 to 3 grams per day found no changes in liver function markers. That said, one trial in people with existing liver cirrhosis did flag modest enzyme increases worth understanding.
What HMB Is and How Your Liver Processes It
HMB is a natural byproduct of leucine, an amino acid found in protein-rich foods like eggs, chicken, and dairy. Your body produces small amounts of HMB on its own, and the liver is where most of that conversion happens. A specific enzyme found primarily in the liver and kidneys breaks leucine down into HMB, which then travels to your muscles to help with protein synthesis and recovery.
Because the liver already handles HMB production as part of normal amino acid metabolism, supplementing with HMB doesn’t introduce anything foreign. You’re simply giving your body more of a compound it already makes and processes routinely.
What Clinical Trials Show About Liver Safety
The International Society of Sports Nutrition’s position on HMB summarizes the safety data clearly: consuming up to 6 grams of HMB per day for up to 8 weeks produced no changes in liver function, kidney function, or blood chemistry. Two separate year-long studies in elderly men and women found no adverse events or changes in liver markers at doses of 2 to 3 grams daily.
One safety study found that doses up to 76 milligrams per kilogram of body weight per day (roughly 5 to 6 grams for an average adult) had no adverse effects on liver enzyme function, lipid profiles, kidney function, or immune markers. For context, the most common supplemental dose is 3 grams per day, well within this range.
The One Study That Raised a Flag
A randomized clinical trial tested HMB-enriched nutritional supplements in malnourished patients with liver cirrhosis over 12 weeks. The researchers found that HMB supplementation was associated with a 25% increase in GGT (a liver enzyme) and a 13% increase in AST (another liver enzyme) compared to a non-HMB supplement group. ALT, a third common liver marker, did not change significantly.
The researchers described these increases as “unexpected” but noted they stayed within a non-toxic range, below twice the upper limit of normal. No patients experienced adverse events, and bilirubin levels (a broader indicator of liver health) actually decreased in both groups over the study period. Still, the authors recommended that non-HMB supplements be used in cirrhotic patients until larger trials can confirm or rule out these findings.
A separate pilot study in patients with less severe cirrhosis (Child-Pugh A and B classifications) found the opposite: HMB was well tolerated by all patients, no adverse events were documented, and liver function tests were unmodified. The conflicting results likely reflect differences in how sick the patients were and how their damaged livers handled the supplement.
HMB May Actually Protect the Liver
Several animal studies suggest HMB could have a protective effect on liver tissue. In one study, HMB supplementation reduced liver fat, lowering both triglyceride and total cholesterol concentrations in liver tissue. These findings align with earlier research showing HMB reduced fat accumulation in the livers of mice fed high-fat diets. A separate animal study found HMB supplementation alleviated liver injury caused by bacterial toxins.
These results are from animal models, so they don’t translate directly to humans. But they suggest that HMB is more likely to support liver health than harm it, at least in a healthy liver.
Who Should Be Cautious
If your liver is healthy, HMB at standard doses (1.5 to 3 grams per day) has a strong safety record across multiple trials lasting up to a year. Even doses twice that amount showed no liver issues over 8 weeks.
If you have liver cirrhosis or another serious liver condition, the picture is less settled. The modest enzyme elevations seen in one cirrhosis trial weren’t dangerous, but they were statistically significant and unexpected. Until more data is available for this specific population, people with advanced liver disease have reason to be more careful and discuss supplementation with their care team.
For the typical person taking HMB to support muscle recovery or prevent age-related muscle loss, the existing evidence consistently points to liver safety across a wide range of doses and study durations.